BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15555554)

  • 1. 2D7 diabody bound to the alpha2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells.
    Kimura N; Kawai S; Kinoshita Y; Ishiguro T; Azuma Y; Ozaki S; Abe M; Sugimoto M; Hirata Y; Orita T; Okabe H; Matsumoto T; Tsuchiya M
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1201-9. PubMed ID: 15555554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment.
    Sekimoto E; Ozaki S; Ohshima T; Shibata H; Hashimoto T; Abe M; Kimura N; Hattori K; Kawai S; Kinoshita Y; Yamada-Okabe H; Tsuchiya M; Matsumoto T
    Cancer Res; 2007 Feb; 67(3):1184-92. PubMed ID: 17283154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model.
    Matsuoka S; Tsurui H; Abe M; Terashima K; Nakamura K; Hamano Y; Ohtsuji M; Honma N; Serizawa I; Ishii Y; Takiguchi M; Hirose S; Shirai T
    J Exp Med; 2003 Aug; 198(3):497-503. PubMed ID: 12885869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis in human lymphocytes by human anti-HLA class I antibodies.
    Daniel D; Opelz G; Mulder A; Süsal C
    Transplantation; 2003 Apr; 75(8):1380-6. PubMed ID: 12717234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro.
    Gall JM; Davol PA; Grabert RC; Deaver M; Lum LG
    Exp Hematol; 2005 Apr; 33(4):452-9. PubMed ID: 15781336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent.
    Asano R; Sone Y; Makabe K; Tsumoto K; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    Clin Cancer Res; 2006 Jul; 12(13):4036-42. PubMed ID: 16818703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabody-based recombinant formats of humanized IgG-like bispecific antibody with effective retargeting of lymphocytes to tumor cells.
    Asano R; Kawaguchi H; Watanabe Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    J Immunother; 2008 Oct; 31(8):752-61. PubMed ID: 18779744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
    Bremer E; Samplonius DF; Peipp M; van Genne L; Kroesen BJ; Fey GH; Gramatzki M; de Leij LF; Helfrich W
    Cancer Res; 2005 Apr; 65(8):3380-8. PubMed ID: 15833872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
    Uno S; Kinoshita Y; Azuma Y; Tsunenari T; Yoshimura Y; Iida S; Kikuchi Y; Yamada-Okabe H; Fukushima N
    Oncol Rep; 2007 May; 17(5):1189-94. PubMed ID: 17390064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells.
    Nagy ZA; Hubner B; Löhning C; Rauchenberger R; Reiffert S; Thomassen-Wolf E; Zahn S; Leyer S; Schier EM; Zahradnik A; Brunner C; Lobenwein K; Rattel B; Stanglmaier M; Hallek M; Wing M; Anderson S; Dunn M; Kretzschmar T; Tesar M
    Nat Med; 2002 Aug; 8(8):801-7. PubMed ID: 12101408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma.
    Kikuchi Y; Uno S; Kinoshita Y; Yoshimura Y; Iida S; Wakahara Y; Tsuchiya M; Yamada-Okabe H; Fukushima N
    Leuk Res; 2005 Apr; 29(4):445-50. PubMed ID: 15725479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway.
    Ishitsuka K; Hideshima T; Hamasaki M; Raje N; Kumar S; Podar K; Le Gouill S; Shiraishi N; Yasui H; Roccaro AM; Tai YZ; Chauhan D; Fram R; Tamura K; Jain J; Anderson KC
    Oncogene; 2005 Sep; 24(38):5888-96. PubMed ID: 15940263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
    Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M
    Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
    Tai YT; Li XF; Catley L; Coffey R; Breitkreutz I; Bae J; Song W; Podar K; Hideshima T; Chauhan D; Schlossman R; Richardson P; Treon SP; Grewal IS; Munshi NC; Anderson KC
    Cancer Res; 2005 Dec; 65(24):11712-20. PubMed ID: 16357183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior activity of fusion protein scFvRit:sFasL over cotreatment with rituximab and Fas agonists.
    Bremer E; ten Cate B; Samplonius DF; Mueller N; Wajant H; Stel AJ; Chamuleau M; van de Loosdrecht AA; Stieglmaier J; Fey GH; Helfrich W
    Cancer Res; 2008 Jan; 68(2):597-604. PubMed ID: 18199557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
    Nakazato T; Ito K; Ikeda Y; Kizaki M
    Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDA-II, a urinary preparation, induces growth arrest and apoptosis of human leukemia cells through inactivation of nuclear factor-kappaB in a caspase-dependent manner.
    Huang J; Yang M; Liu H; Jin J
    Food Chem Toxicol; 2009 Jan; 47(1):40-9. PubMed ID: 18761050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective induction of cell death on adult T-cell leukaemia cells by HLA-DRbeta-specific small antibody fragment isolated from human antibody phage library.
    Muraoka S; Ito Y; Kamimura M; Baba M; Arima N; Suda Y; Hashiguchi S; Torikai M; Nakashima T; Sugimura K
    J Biochem; 2009 Jun; 145(6):799-810. PubMed ID: 19270058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of novel murine anti-CD20 monoclonal antibodies and their comparison to 2B8 and c2B8 (rituximab).
    Nishida M; Usuda S; Okabe M; Miyakoda H; Komatsu M; Hanaoka H; Teshigawara K; Niwa O
    Int J Oncol; 2007 Jul; 31(1):29-40. PubMed ID: 17549402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.